Epi proColon Publikationen

Mehr Informationen

Epi proColon® 2.0 CE Publications

Year Citation
2017 Song et al. (Scientific Reports): The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis
2017 Lamb et al. (Mol Diagn Ther.): Epi proColon® CE: A Blood-Based Screening Test for Colorectal Cancer
2017 Nian et al. (Clin Transl Gastroenterol.): Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis
2017 Song et al. (J Cancer Res Clin Oncol): The performance of the mSEPT9 assay is influenced by algorithm,
cancer stage and age, but not sex and cancer location
2016 Li et al. (Plos One): Diagnostic performance of DNA hypermethylation markers in peripheral blood for the detection of colorectal cancer: a meta-analysis an systematic review
2016 Wu et al. (J Mol Diagn ): Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening
2016 Toth et al. (Pathol. Oncol. Res.): Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients
2016 Song and Li (World J Gastrointest Oncol): Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests
2015 Orntoft et al. (BMC Cancer ): Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study
2014 Ladabaum et al. (Endoscopy International Open): Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA
2014 Toth et al. (PLoS One): Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA.
2014 Li et al. (Biomarkers Med. ): Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future
2014 Jin et al. (, J. Gastroenterol. Hepatol.): Performance of a second generation methylated SEPT9 test in detecting colorectal neoplasm
2014 Molnar et al. (Expert Rev. Mol. Diagn.): Plasma methylated septin 9: a colorectal cancer screening marker
2014 Adler et al. ( BMC Gastroenterology): Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany
2014 deVos (Clinical Laboratory International ): Blood-based tests for colorectal cancer screening
2013 Wasserkort et al. (BMC Cancer): Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island
2013 Ladabaum et al. (Cancer Epidemiology, Biomarkers & Prevention): Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated Septin9 DNA vs. current strategies
2012 Lofton-Day C et al. (Practical Gastroenterology): Opportunities and limitations of blood-based CRC screening tests. 
2012 Toth et al. (PLOS One): Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers
2011 Toth et al. (Pathology and Oncology Research): The Influence of Methylated Septin 9 Gene on RNA and Protein Level in Colorectal Cancer.
2010 Payne S et al. (Epigenomics): From discovery to the clinic: the novel DNA methylation biomarker mSEPT9 for the detection of colorectal cancer in blood.
2010 Tanzer et al. (PLOS ONE): Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions 
2010 Weiss and Rösch (European Oncology): Potential of a New Blood Test for Colorectal Cancer Screening – The Septin 9 Gene Biomarker
2009 deVos T et al. (Clinical Chemistry): Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
2008 Lofton-Day C et al. (Clinical Chemistry): DNA methylation biomarkers for blood-based colorectal cancer screening.
2008 Grützmann et al. (PLoS One): Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin9 DNA Methylation Assay